{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T13:55:00Z","timestamp":1785678900642,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":3419,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1038\/modpathol.2013.65","type":"journal-article","created":{"date-parts":[[2013,4,19]],"date-time":"2013-04-19T07:43:53Z","timestamp":1366357433000},"page":"1204-1210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms"],"prefix":"10.1016","volume":"26","author":[{"given":"Jessica A","family":"Hemminger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O Hans","family":"Iwenofu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2013.65_bib1","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/ijc.22239","article-title":"Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: an analysis of 26,758 cases","volume":"119","author":"Toro","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2013.65_bib2","series-title":"Enzinger and Weiss's Soft Tissue Tumors","first-page":"477","article-title":"Liposarcoma","author":"Weiss","year":"2008"},{"key":"10.1038\/modpathol.2013.65_bib3","first-page":"3977","article-title":"Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases","volume":"7","author":"Antonescu","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.65_bib4","first-page":"489","article-title":"Fusion of the EWS and CHOP genes in myxoid liposarcoma","volume":"12","author":"Panagopoulos","year":"1996","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2013.65_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1034\/j.1600-065X.2002.18803.x","article-title":"Cancer\/testis antigens: an expanding family of targets for cancer immunotherapy","volume":"188","author":"Scanlan","year":"2002","journal-title":"Immunol Rev"},{"key":"10.1038\/modpathol.2013.65_bib6","first-page":"7","article-title":"The frequent expression of cancer\/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma","volume":"4","author":"Ayyoub","year":"2004","journal-title":"Cancer Immun"},{"key":"10.1038\/modpathol.2013.65_bib7","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1093\/humrep\/der330","article-title":"Chromosome X-encoded cancer\/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma","volume":"26","author":"Chen","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1038\/modpathol.2013.65_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1711.2006.01446.x","article-title":"Directions in the immune targeting of cancer: lessons learned from the cancer-testis AgNY-ESO-1","volume":"84","author":"Nicholaou","year":"2006","journal-title":"Immunol Cell Biol"},{"key":"10.1038\/modpathol.2013.65_bib9","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1073\/pnas.94.5.1914","article-title":"A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening","volume":"94","author":"Chen","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2013.65_bib10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.1282","article-title":"Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues","volume":"92","author":"Jungbluth","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2013.65_bib11","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1002\/cncr.27446","article-title":"NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid\/round cell liposarcoma","volume":"118","author":"Pollack","year":"2012","journal-title":"Cancer"},{"key":"10.1038\/modpathol.2013.65_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/modpathol.2012.133","article-title":"The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas","volume":"26","author":"Hemminger","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.65_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000134734","article-title":"Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28","volume":"79","author":"Chen","year":"1997","journal-title":"Cytogenet Cell Genet"},{"key":"10.1038\/modpathol.2013.65_bib14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/jcp.10215","article-title":"Cancer\/testis-associated genes: identification, expression profile, and putative function","volume":"194","author":"Zendman","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1038\/modpathol.2013.65_bib15","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1158\/0008-5472.CAN-04-1882","article-title":"Cancer\/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression","volume":"65","author":"Cronwright","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2013.65_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3892\/ol.2011.441","article-title":"NY-ESO-1 expression in hepatocellular carcinoma: a potential new marker for early recurrence after surgery","volume":"3","author":"Xu","year":"2012","journal-title":"Oncol Lett"},{"key":"10.1038\/modpathol.2013.65_bib17","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1158\/1078-0432.CCR-05-1203","article-title":"Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer","volume":"11","author":"Gure","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2013.65_bib18","doi-asserted-by":"crossref","first-page":"12198","DOI":"10.1073\/pnas.220413497","article-title":"Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers","volume":"97","author":"Jager","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2013.65_bib19","doi-asserted-by":"crossref","first-page":"12837","DOI":"10.1073\/pnas.0703342104","article-title":"Vaccination with an NY-ESO-1 peptide of HLA class I\/II specificities induces integrated humoral and T cell responses in ovarian cancer","volume":"104","author":"Odunsi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2013.65_bib20","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/j.1349-7006.2009.01303.x","article-title":"Cancer\/testis (CT) antigens: potential targets for immunotherapy","volume":"100","author":"Caballero","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1038\/modpathol.2013.65_bib21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","article-title":"Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1","volume":"29","author":"Robbins","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2013.65_bib22","doi-asserted-by":"crossref","first-page":"e38783","DOI":"10.1371\/journal.pone.0038783","article-title":"NY-ESO-1 cancer testis antigen demonstrates high immunogenicity in triple negative breast cancer","volume":"7","author":"Ademuyiwa","year":"2012","journal-title":"PloS ONE"},{"key":"10.1038\/modpathol.2013.65_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ijc.1451","article-title":"Monophasic and biphasic synovial sarcomas abundantly express cancer\/testis antigen NY-ESO-1 but not MAGE-A1 or CT7","volume":"94","author":"Jungbluth","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2013.65_bib24","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/ijc.23698","article-title":"Cancer testis antigen expression in gastrointestinal stromal tumors: new markers for early recurrence","volume":"123","author":"Perez","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1038\/modpathol.2013.65_bib25","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/modpathol.2012.31","article-title":"NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis","volume":"25","author":"Lai","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2013.65_bib26","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1158\/1078-0432.CCR-07-5279","article-title":"Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer","volume":"14","author":"Woloszynska-Read","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol201365.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201365","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222030496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222030496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol201365.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:07:12Z","timestamp":1760231232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222030496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0893395222030496"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2013.65","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2013.65","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}